| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $807.8M | +3.2% |
| R&D Expense | $67.6M | +11.7% |
| SG&A Expense | $4.0M | +14.3% |
| Operating Income | $179.3M | -16.0% |
| Pre-tax Income | $101.6M | -35.5% |
| Income Tax | $17.6M | -52.6% |
| Net Income | $84.0M | -30.3% |
| EPS (Basic) | $0.96 | -27.8% |
| EPS (Diluted) | $0.91 | -26.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $267.2M | -8.9% |
| Accounts Receivable | $107.9M | -9.2% |
| Inventory | $70.6M | +21.0% |
| Current Assets | $931.5M | +20.5% |
| Total Assets | $2.12B | +10.7% |
| Current Liabilities | $884.5M | +27.9% |
| Long-term Debt | $974.5M | -0.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $292.2M | +7.2% |
| Investing Cash Flow | -$204.3M | -13.9% |
| Financing Cash Flow | -$110.9M | -10.3% |
| Total Liabilities |
| $1.90B |
| +11.6% |
| Stockholders' Equity | $226.1M | +3.9% |